# Vertex Pharmaceuticals Inc / Ma: filings

VRTX · Nasdaq · CIK 875320 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vrtx.md) · [Financials](/companies/vrtx/financials.md) · [Filings](/companies/vrtx/filings.md) · [Insiders](/companies/vrtx/insiders.md)

## Reports and events: 287 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1920, 144 188, 8-K 185, SC 13G/A 79, 10-Q 53, 3 42, UPLOAD 26, CORRESP 24, SC 13G 21, 10-K 18, CT ORDER 18, DEF 14A 18, S-8 13, DEFA14A 12, ARS 11, PX14A6G 9, 424B5 7, S-3ASR 7, S-8 POS 7, SCHEDULE 13G/A 6, 5 5, 4/A 4, 8-K/A 4, SC 13D/A 4, 10-Q/A 3, NO ACT 3, PRE 14A 3, SC TO-C 3, SC TO-T/A 3, SC 13D 2, SCHEDULE 13G 2, SEC STAFF LETTER 2, 3/A 1, D 1, EFFECT 1, FWP 1, POS AM 1, SC TO-T 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-20 | 20:09 ET | [8-K](/filings/0000875320-26-000278.md) | 5.02 Departure or appointment of officers or directors | 0000875320-26-000278 |
| 2026-09-01 | 20:25 ET | [8-K](/filings/0000875320-26-000264.md) | 5.02 Departure or appointment of officers or directors | 0000875320-26-000264 |
| 2026-08-04 | 20:08 ET | [10-Q](/filings/0000875320-26-000259.md) | Quarterly report, period 2026-06-30 | 0000875320-26-000259 |
| 2026-08-03 | 20:09 ET | [8-K](/filings/0000875320-26-000256.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-26-000256 |
| 2026-07-07 | 01:55 ET | [8-K](/filings/0001193125-26-296710.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-296710 |
| 2026-05-13 | 20:03 ET | [8-K](/filings/0000875320-26-000204.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000875320-26-000204 |
| 2026-05-05 | 20:08 ET | [10-Q](/filings/0000875320-26-000173.md) | Quarterly report, period 2026-03-31 | 0000875320-26-000173 |
| 2026-05-04 | 20:05 ET | [8-K](/filings/0000875320-26-000171.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-26-000171 |
| 2026-04-29 | 20:05 ET | [8-K](/filings/0000875320-26-000166.md) | 5.02 Departure or appointment of officers or directors | 0000875320-26-000166 |
| 2026-04-02 | 20:02 ET | [DEF 14A](/filings/0000875320-26-000153.md) | Proxy statement, period 2026-05-13 | 0000875320-26-000153 |
| 2026-03-31 | 20:03 ET | [8-K](/filings/0000875320-26-000147.md) | 8.01 Other events | 0000875320-26-000147 |
| 2026-02-13 | 21:20 ET | [10-K](/filings/0000875320-26-000056.md) | Annual report, period 2025-12-31 | 0000875320-26-000056 |
| 2026-02-12 | 21:04 ET | [8-K](/filings/0000875320-26-000034.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-26-000034 |
| 2025-11-04 | 21:03 ET | [10-Q](/filings/0000875320-25-000232.md) | Quarterly report, period 2025-09-30 | 0000875320-25-000232 |
| 2025-11-03 | 21:06 ET | [8-K](/filings/0000875320-25-000230.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-25-000230 |
| 2025-08-05 | 20:02 ET | [10-Q](/filings/0000875320-25-000216.md) | Quarterly report, period 2025-06-30 | 0000875320-25-000216 |
| 2025-08-04 | 20:06 ET | [8-K](/filings/0000875320-25-000213.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000875320-25-000213 |
| 2025-05-19 | 20:24 ET | [8-K](/filings/0000875320-25-000199.md) | 8.01 Other events | 0000875320-25-000199 |
| 2025-05-14 | 20:08 ET | [8-K](/filings/0000875320-25-000194.md) | 5.07 Shareholder vote results | 0000875320-25-000194 |
| 2025-05-06 | 20:04 ET | [10-Q](/filings/0000875320-25-000192.md) | Quarterly report, period 2025-03-31 | 0000875320-25-000192 |
| 2025-05-05 | 20:10 ET | [8-K](/filings/0000875320-25-000171.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-25-000171 |
| 2025-04-03 | 20:02 ET | [DEF 14A](/filings/0000875320-25-000160.md) | Proxy statement, period 2025-05-14 | 0000875320-25-000160 |
| 2025-03-28 | 20:08 ET | [8-K](/filings/0000875320-25-000156.md) | 8.01 Other events | 0000875320-25-000156 |
| 2025-02-13 | 21:01 ET | [10-K](/filings/0000875320-25-000053.md) | Annual report, period 2024-12-31 | 0000875320-25-000053 |
| 2025-02-10 | 21:08 ET | [8-K](/filings/0000875320-25-000029.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000875320-25-000029 |
| 2024-12-20 | 20:51 ET | [8-K](/filings/0000875320-24-000231.md) | 7.01 Regulation FD disclosure | 0000875320-24-000231 |
| 2024-11-05 | 21:11 ET | [10-Q](/filings/0000875320-24-000223.md) | Quarterly report, period 2024-09-30 | 0000875320-24-000223 |
| 2024-11-04 | 21:02 ET | [8-K](/filings/0000875320-24-000221.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-24-000221 |
| 2024-08-16 | 20:04 ET | [8-K](/filings/0000875320-24-000207.md) | 1.01 Entry into a material agreement | 0000875320-24-000207 |
| 2024-08-02 | 20:03 ET | [10-Q](/filings/0000875320-24-000198.md) | Quarterly report, period 2024-06-30 | 0000875320-24-000198 |
| 2024-08-01 | 20:05 ET | [8-K](/filings/0000875320-24-000193.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-24-000193 |
| 2024-06-27 | 20:05 ET | [8-K](/filings/0000875320-24-000178.md) | 8.01 Other events | 0000875320-24-000178 |
| 2024-05-20 | 12:36 ET | [8-K](/filings/0001193125-24-142278.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-142278 |
| 2024-05-15 | 20:12 ET | [8-K](/filings/0000875320-24-000142.md) | 5.07 Shareholder vote results | 0000875320-24-000142 |
| 2024-05-07 | 20:14 ET | [10-Q](/filings/0000875320-24-000139.md) | Quarterly report, period 2024-03-31 | 0000875320-24-000139 |
| 2024-05-06 | 20:03 ET | [8-K](/filings/0000875320-24-000137.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-24-000137 |
| 2024-04-11 | 11:13 ET | [8-K](/filings/0001193125-24-092475.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-092475 |
| 2024-04-04 | 20:01 ET | [DEF 14A](/filings/0001308179-24-000452.md) | Proxy statement, period 2023-05-15 | 0001308179-24-000452 |
| 2024-02-15 | 21:12 ET | [10-K](/filings/0000875320-24-000062.md) | Annual report, period 2023-12-31 | 0000875320-24-000062 |
| 2024-02-05 | 21:09 ET | [8-K](/filings/0000875320-24-000012.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-24-000012 |
| 2023-12-08 | 17:59 ET | [8-K](/filings/0000875320-23-000054.md) | 8.01 Other events | 0000875320-23-000054 |
| 2023-12-05 | 21:14 ET | [8-K](/filings/0000875320-23-000047.md) | 5.02 Departure or appointment of officers or directors | 0000875320-23-000047 |
| 2023-11-07 | 21:16 ET | [10-Q](/filings/0000875320-23-000031.md) | Quarterly report, period 2023-09-30 | 0000875320-23-000031 |
| 2023-11-06 | 21:05 ET | [8-K](/filings/0000875320-23-000029.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-23-000029 |
| 2023-10-05 | 20:01 ET | [8-K](/filings/0000875320-23-000023.md) | 5.02 Departure or appointment of officers or directors | 0000875320-23-000023 |
| 2023-08-02 | 20:05 ET | [10-Q](/filings/0000875320-23-000021.md) | Quarterly report, period 2023-06-30 | 0000875320-23-000021 |
| 2023-08-01 | 20:03 ET | [8-K](/filings/0000875320-23-000019.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000875320-23-000019 |
| 2023-06-05 | 16:10 ET | [SC 13D/A](/filings/0001341004-23-000148.md) | Ownership report, active investor, amended | 0001341004-23-000148 |
| 2023-05-18 | 12:56 ET | [8-K](/filings/0000875320-23-000015.md) | 5.07 Shareholder vote results | 0000875320-23-000015 |
| 2023-05-02 | 20:07 ET | [10-Q](/filings/0000875320-23-000012.md) | Quarterly report, period 2023-03-31 | 0000875320-23-000012 |

Page 1 of 6. [Older](/companies/vrtx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.